While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective. Turning its potential into real-world health care outcomes, researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have successfully utilized an AI platform to make precise recommendations for dose adjustments in 10 patients at the National University Cancer Institute, Singapore (NCIS) in Singapore.
AI ‘digital twin’ platform personalizes cancer treatment dosing in research trial
-
HighlightsFree Dark Web Monitoring Stamps the $17 Million Credentials Markets
-
HighlightsSmart buildings: What happens to our free will when tech makes choices for us?
-
AppsScreenshots have generated new forms of storytelling, from Twitter fan fiction to desktop film
-
HighlightsDarknet markets generate millions in revenue selling stolen personal data, supply chain study finds
-
SecurityPrivacy violations undermine the trustworthiness of the Tim Hortons brand
-
Featured HeadlinesWhy Tesla’s Autopilot crashes spurred the feds to investigate driver-assist technologies – and what that means for the future of self-driving cars
